Acceder Registro /

PABLO PELEGRIN VIVANCOS

Buscador

Compan V, Baroja-Mazo A, López-Castejón G, Gomez AI, Martínez CM, Angosto D, Montero MT, Herranz AS, Bazán E, Reimers D, Mulero V, Pelegrín P. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity. 2012 Sep 21;37(3):487-500. doi: 10.1016/j.immuni.2012.06.013. Epub 2012 Sep 13. PubMed PMID: 22981536.
AÑO: 2012; IF: 19.795
Machado-Linde F, Pelegrin P, Sanchez-Ferrer ML, Leon J, Cascales P, Parrilla JJ. 2-methoxyestradiol in the pathophysiology of endometriosis: focus on angiogenesis and therapeutic potential. Reprod Sci. 2012 Oct;19(10):1018-29. doi: 10.1177/1933719112446080. Epub 2012 Aug 8. Review. PubMed PMID: 22875846.
AÑO: 2012; IF: 2.064
Compan V, Baroja-Mazo A, Bragg L, Verkhratsky A, Perroy J, Pelegrin P. A genetically encoded IL-1? bioluminescence resonance energy transfer sensor to monitor inflammasome activity. J Immunol. 2012 Sep 1;189(5):2131-7. doi: 10.4049/jimmunol.1201349. Epub 2012 Jul 18. PubMed PMID: 22815289; PubMed Central PMCID: PMC3437522.
AÑO: 2012; IF: 5.52
Barberà-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Pelegrín P. P2X7 receptor-stimulation causes fever via PGE2 and IL-1? release. FASEB J. 2012 Jul;26(7):2951-62. doi: 10.1096/fj.12-205765. Epub 2012 Apr 6. PubMed PMID: 22490780.
AÑO: 2012; IF: 5.704
Baroja-Mazo A, Pelegrín P. Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates. J Osteoporos. 2012;2012:408242. doi: 10.1155/2012/408242. Epub 2012 Jul 8. PubMed PMID: 22830074; PubMed Central PMCID: PMC3399340.
AÑO: 2012

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R